Zachariah Serber - Sep 2, 2022 Form 4 Insider Report for Zymergen Inc. (ZY)

Role
Chief Science Officer, Director
Signature
/s/ Celeste Ferber, attorney-in-fact
Stock symbol
ZY
Transactions as of
Sep 2, 2022
Transactions value $
-$7,222
Form type
4
Date filed
9/7/2022, 07:27 PM
Previous filing
Aug 15, 2022
Next filing
Oct 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZY Common Stock Sale -$7.22K -3.27K -0.13% $2.21 2.55M Sep 2, 2022 Direct F1, F2
holding ZY Common Stock 40K Sep 2, 2022 See Footnote F3
holding ZY Common Stock 40K Sep 2, 2022 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $2.31 and no less than $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Held by the Rorik Serber 2021 Irrevocable Trust.
F4 Held by spouse as custodian for children under the California Uniform Transfer to Minors Act.